小摩上调罗氏目标价至350瑞士法郎

Group 1 - Morgan Stanley upgraded Roche's rating from "Underweight" to "Neutral" [1] - The target price for Roche was raised from 230 Swiss Francs to 350 Swiss Francs [1]